Comments on treatment strategy for locally advanced non-small cell lung cancer

Lung Cancer

Volumn 38, Issue 3 SUPPL., 2002, Pages 33-35

  Zwitter, Matjaz ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Chemotherapy; Non small cell lung cancer (NSCLC); Radiotherapy; Therapeutic nihilism

Indexed keywords

GEMCITABINE; NAVELBINE; PLATINUM; TAXANE DERIVATIVE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DOSIMETRY; HEALTH SURVEY; HUMAN; IRRADIATION; LOCAL THERAPY; LUNG NON SMALL CELL CANCER; METASTASIS; ONCOLOGY; PRIORITY JOURNAL; SURVIVAL TIME; SYSTEMIC THERAPY;

EID: 0036896696     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0169-5002(02)00265-9     Document Type: Article

References (10)

1. Saunders M., Dische S., Barrett A., Harvey A., Griffiths G., Parmar M. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomized multicentre trial. Radiother. Oncol. 52:1999;137-148.
2. Castellano D., Lianes P., Paz-Ares L. A phase II study of a novel gemcitabine plus cisplatin regimen administered every 3 weeks for advanced non-small cell lung cancer. Ann. Oncol. 9:1998;457-459.
3. Zwitter M., Cufer T., Wein W. Gemcitabine and vincristine: an effective outpatient regimen with low myelotoxicity for stage IV non-small cell lung cancer. Neoplasma. 48:2001;200-202.
4. Van Zandwijk N., Smit E.F., Kramer G.W., et al. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). J. Clin. Oncol. 18:2000;2658-2664.
5. Jassem J. Combined chemotherapy and radiation in locally advanced non-small cell lung cancer. Lancet Oncol. 2:2001;335-342.
6. Leu K.M., Kim K., Larson M., Larson M., Schiller J.H. Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. Lung Cancer. 34:2001;105-113.
7. Martini N., Bains M., Burt M. Incidence of local recurrence and secondary primary tumors in resected stage I lung cancer. J. Thorac. Cardiovasc. Surg. 109:1995;120-129.
8. Martini N., Burt M., Bains M. Survival after resection of stage II non-small cell lung cancer. Ann. Thorac. Surg. 54:1992;460-466.
9. Perez C.A., Pajak T.F., Rubin P. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer. 59:1987;1874-1881.
10. Baumann M. Accelerated radiation therapy in non-small cell lung cancer. Radiother. Oncol. 52:1999;97-99.